1,090 results on '"Paik, S"'
Search Results
52. Yakiniku Dragon as Prophecy and Reflection
53. Macrophagic myofasciitis unrelated to vaccination
54. Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37298 women with early breast cancer in 26 randomised trials
55. Epidemiology
56. Clinical features of liver abscess developed after local treatment for hepatocelluar carcinoma: APASL\Abstract\246
57. Efficacy and safety of adefovir dipivoxil in compensated and decompensated subjects with lamivudine resistance: APASL\Abstract\213
58. Oxidant and SDS-stable alkaline protease from Bacillus clausii I-52: production and some properties
59. Encapsulation of Water-Soluble Dye in Spherical Sol-Gel Silica Matrices
60. Expression of an artificial polypeptide with a repeated tripeptide glutamyl–tryptophanyl–lysine in Saccharomyces cerevisiae
61. Modeling of an inductively coupled plasma at reduced pressures
62. Total Synthesis of Cryptophycin C
63. HUMAN B7-1(CD80) GENE TRANSFER ELICITS PROTECTIVE IMMUNITY AGAINST HEPATOCELLULAR CARCINOMA IN ATHYMIC NUDE MICE
64. SIGNIFICANCE OF ENGARGED PERIHEPATIC LYMPH NODES IN PATIENTS WITH CHRONIC HEPATITIS B
65. SOMATOSTATIN VERSUS BALLOON TAMPONADE FOR TEMPORARY HEMOSTASIS OF BLEEDING ESOPHAGEAL VARICES BEFORE ENDOSCOPIC VARICEAL LIGATION (EVL): A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL
66. Clinical outcomes by chemotherapy regimen in patients with RS 26-100 in TAILORx
67. Dosimetric Analysis of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer in NRG Oncology’s RTOG 1203
68. Abstract No. 526 CheckMate-9DX: phase 3, randomized, double-blind study of adjuvant nivolumab vs placebo for patients with hepatocellular carcinoma (HCC) at high risk of recurrence after curative resection or ablation
69. Abstract GS4-04: Primary results of NSABP B-39/RTOG 0413 (NRG Oncology): A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, or II breast cancer
70. Abstract OT2-04-01: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to whole breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence-free interval (IBCR-FI) in patients (pts) with pathologically positive axillary (PPAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC): NRG Oncology/NSABP B-51/RTOG 1304
71. Abstract GS4-07: Race, ethnicity and clinical outcomes in hormone receptor-positive, HER2-negative, node-negative breast cancer: results from the TAILORx trial
72. Abstract P3-10-04: The fully validated NSABP/NRG 8-gene signature which predicted the degree of benefit in the adjuvant setting (B-31 and NCCTG N9831) associates with pCR in the neoadjuvant setting in NSABP clinical trial FB-7
73. A Study on Finite Deformation of Copper Crystals Using the Principlesof Crystal Plasticity: Experiments and Simulations
74. Complete sequence analysis of human norovirus GII.17 detected in South Korea
75. 20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years
76. CAN INNOVATION BE TAUGHT?
77. Nephrogenic adenoma arising in an urethral diverticulum
78. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
79. Summary of Surface Swipe Sampling for Beryllium on Lead Bricks and Shielding
80. Genomic profiling of the residual disease of advanced high-grade serous ovarian cancer after neoadjuvant chemotherapy
81. Abstract GS1-02: NSABP B-47 (NRG oncology): Phase III randomized trial comparing adjuvant chemotherapy with adriamycin (A) and cyclophosphamide (C) → weekly paclitaxel (WP), or docetaxel (T) and C with or without a year of trastuzumab (H) in women with node-positive or high-risk node-negative invasive breast cancer (IBC) expressing HER2 staining intensity of IHC 1+ or 2+ with negative FISH (HER2-Low IBC)
82. Abstract OT2-03-02: NRG oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence-free interval (IBCR-FI) in patients (pts) with positive axillary (PAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC)
83. A171 MINIMAL CHANGES IN URINE MARKERS OF TUBULAR DYSFUNCTION IN CHB PATIENTS RECEIVING TAF COMPARED WITH TDF
84. Evaluating the Environmental Impacts of Pavement Maintenance Strategies Based on Life Cycle Assessment
85. Association Between Premature Hair Greying and Metabolic Risk Factors: A Cross-sectional Study
86. Applying design methods to care delivery science: Improving the care of minority children with uncontrolled asthma and their caregivers who present to six Emergency Departments in Chicago through a stakeholder-optimized discharge tool
87. P1.06-015 Analysis of Relationship Between Non-Small Cell Lung Cancer and Nicotine Dependence
88. Keeping up with the pace of digitization: The case of the Australian construction industry
89. EFFECTIVENESS OF PEGINTERFERON ALFA-2A THERAPY IN HBEAG-POSITIVE AND HBEAG-NEGATIVE PATIENTS WITH CHRONIC HEPATITIS B: FINAL RESULTS 3 YEARS POST-TREATMENT OF THE PROSPECTIVE, GLOBAL, OBSERVATIONAL S-COLLATE STUDY
90. SCDAP/RELAP5 modeling of heat transfer and flow losses in lower head porous debris. Revision 1
91. Design of a pragmatic trial in minority children presenting to the emergency department with uncontrolled asthma: The CHICAGO Plan
92. Effect of extended adjuvant endocrine therapy with letrozole (L) in postmenopausal women with hormone-receptor (+) breast cancer after prior adjuvant therapy with an aromatase inhibitor (AI): NRG Oncology/NSABP B-42
93. Abstract S1-05: A randomized, double-blinded, placebo-controlled clinical trial of extended adjuvant endocrine therapy (tx) with letrozole (L) in postmenopausal women with hormone-receptor (+) breast cancer (BC) who have completed previous adjuvant tx with an aromatase inhibitor (AI): Results from NRG Oncology/NSABP B-42
94. Abstract OT2-03-01: NRG oncology/NSABP B-51/RTOG 1304: A phase III superiority clinical trial designed to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) will reduce invasive cancer events in patients (pts) with positive axillary (Ax) nodes and convert to ypN0 after neoadjuvant chemotherapy (NC)
95. Abstract S3-06: A phase III trial evaluating pCR in patients with HR+, HER2-positive breast cancer treated with neoadjuvant docetaxel, carboplatin, trastuzumab, and pertuzumab (TCHP) +/- estrogen deprivation: NRG Oncology/NSABP B-52
96. Modeling of thermal plasma arc technology FY 1994 report
97. Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials
98. Non-alcoholic fatty liver diseases and risk of colorectal neoplasia
99. LBA18 - Clinical outcomes by chemotherapy regimen in patients with RS 26-100 in TAILORx
100. Slow-Wave Parametric Pumping of the Electrostatic Wave in a Plasma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.